Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Intangibles (2024 - 2025)

Kairos Pharma's Intangibles history spans 2 years, with the latest figure at $62000.0 for Q4 2025.

  • For Q4 2025, Intangibles fell 72.07% year-over-year to $62000.0; the TTM value through Dec 2025 reached $62000.0, down 72.07%, while the annual FY2025 figure was $62000.0, 72.07% down from the prior year.
  • Intangibles reached $62000.0 in Q4 2025 per KAPA's latest filing, down from $142000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $262000.0 in Q3 2024 to a low of $62000.0 in Q4 2025.